Woodmont Investment Counsel’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
Woodmont Investment Counsel's CDNA Position: Q4 2021 in Review
Woodmont Investment Counsel sold out of CareDx (CDNA) in Q4 2021, closing a stake of 7,013 shares — an estimated $444K sold.
Woodmont Investment Counsel first reported a position in CDNA in Q4 2017 and held it in 10 quarters. The position peaked at $726K in Q1 2018. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.
- Woodmont Investment Counsel reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
- Woodmont Investment Counsel sold 7,013 CareDx shares in Q4 2021, an estimated $444K.
- Woodmont Investment Counsel first reported a position in CareDx in Q4 2017 and held it in 10 quarters.
- Woodmont Investment Counsel's CareDx position peaked at $726K in Q1 2018.
- 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.
Based on Woodmont Investment Counsel's 13F filing for Q4 2021, filed 2 Feb 2022.